Key Dates

Related Announcements

• July 3, 2024 - PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required).  See NOFO PA-24-246.

Issued by

National Institute on Drug Abuse (NIDA)

Purpose

This Notice informs potential applicants that the National Institute on Drug Abuse (NIDA) will participate in PA-24-246, PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required).

The following sections of PA-24-246 have been modified to reflect NIDA's participation. Changes are made in Bold Italic.

Part 1. Overview Information

Components of Participating Organizations

NATIONAL INSTITUTES OF HEALTH (NIH)

National Eye Institute (NEI)

National Heart, Lung, and Blood Institute (NHLBI)

National Human Genome Research Institute (NHGRI)

National Institute on Aging (NIA)

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

National Institute of Biomedical Imaging and Bioengineering (NIBIB)

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

National Institute on Deafness and Other Communication Disorders (NIDCD)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

National Institute of Environmental Health Sciences (NIEHS)

National Institute of Mental Health (NIMH)

National Institute of Nursing Research (NINR)

National Institute on Minority Health and Health Disparities (NIMHD)

National Library of Medicine (NLM)

National Center for Complementary and Integrative Health (NCCIH)

National Cancer Institute (NCI)

National Institute on Drug Abuse (NIDA)

CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC)
Global Health Center(GHC/CDC)
Office of Readiness and Response (ORR - CPR/CDC)
National Center on Birth Defects and Developmental Disabilities (NCBDDD/CDC)
National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP/CDC)
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID/CDC)
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP/CDC)
National Center for Injury Prevention and Control (NCIPC/CDC)
National Center for Immunization and Respiratory Diseases (NCIRD/CDC)
National Institute for Occupational Safety and Health (NIOSH/CDC)
National Center for Environmental Health (NCEH/CDC)

Assistance Listing Number(s)

93.286, 93.173, 93.847, 93.865, 93.867, 93.273, 93.879, 93.233, 93.837, 93.838, 93.839, 93.840, 93.361, 93.172, 93.143, 93.113, 93.142, 93.393, 93.394, 93.395, 93.213, 93.866, 93.307, 93.242, 93.279

All other aspects of the NOFO remain the same.

Inquiries

Please direct all inquiries to:

Elena Koustova, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-497-8768
Email: koustovae@mail.nih.gov